Skip to main content
SpringerLink
Log in

Characterization of zinc effect to inhibit osteoclast-like cell formation in mouse marrow culture: Interaction with dexamethasone

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The inhibitory effect of zinc compounds on osteoclast-like cell formation in mouse marrow culture in vitro was characterized. The bone marrow cells were cultured for 7 days in α-minimal essential medium containing a well-known bone resorbing agent, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] or prostaglandin E2 (PGE2). Osteoclast-like cell formation was estimated by staining for tartrate-resistant acid phosphatase (TRACP), a marker enzyme of osteoclasts. The presence of 1,25(OH)2D3 (10-8 M) or PGE2 (10-6 M) induced a remarkable increase in osteoclast-like multinucleated cells. These increases were enhanced by the presence of dexamethasone (10-9 to 10-6 M). The dexamethasone (10-7 M)-enhanced osteoclast-like cell formation was not inhibited by the presence of zinc sulfate (10-6 M) or zinc-chelating dipeptide (β-alanyl-L-histidinato zinc; 10-6 M), although the zinc compounds had an inhibitory effect on osteoclastic formation in the absence of the steroid. The effect of dexamethasone was not seen, when the steroid was added at the later stage of culture with bone-resorbing agents. In this case, the inhibitory effect of zinc compounds was clearly revealed. This effect of zinc compounds disappeared in the presence of Ca2+-chelating agent (0.5 mM EGTA). The present study suggests that zinc compounds have an inhibitory effect at the stage of differentiation of preosteoclastic cells in bone marrow cell culture system. (Mol Cell Biochem 166: 145-151, 1997)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Burch RE, Hahn HKJ, Sullivan JF: Newer aspects of the roles of the zinc, manganese, and copper in human nutrition. Clin Chem 21: 501–520, 1975

    Google Scholar 

  2. Hurley LS, Gowan J, Milhaud G: Calcium metabolism in manganese-deficient and zinc-deficient rats. Proc Soc Exp Biol Med 130: 856–860, 1969

    Google Scholar 

  3. Oner G, Bhaumick B, Bala RM: Effect of zinc deficiency on serum somatomedin levels and skeletal growth in young rats. Endocrinology 114: 1860–1863, 1984

    Google Scholar 

  4. Yamaguchi M, Yamaguchi R: Action of zinc on bone metabolism in rats. Increases in alkaline phosphatase activity and DNA content. Biochem Pharmacol 35: 773–777, 1986

    Google Scholar 

  5. Yamaguchi M, Oishi H, Suketa Y: Stimulatory effect of zinc on bone formation in tissue culture. Biochem Pharmacol 36: 4007–4012, 1987

    Google Scholar 

  6. Yamaguchi M, Oishi H, Suketa Y: Zinc stimulation of bone protein synthesis in tissue culture. Activation of aminoacyl-tRNA synthetase. Biochem Pharmacol 37: 4075–4080, 1988

    Google Scholar 

  7. Yamaguchi M, Ozaki K: A new zinc compound, β-analyl-L-histidinato zinc, stimulates bone growth in weanling rats. Res Exp Med (Berl) 190: 105–110, 1990

    Google Scholar 

  8. Yamaguchi M, Ozaki K: Effect of the new zinc compound beta-alanyl-L-histidinato zinc on bone metabolism in elderly rats. Pharmacology 41: 345–349, 1990

    Google Scholar 

  9. Yamaguchi M, Miwa H: Stimulatory effect of beta-alanyl-L-histidinato zinc on bone formation in tissue culture. Pharmacology 42: 230–240, 1991

    Google Scholar 

  10. Hashizume M, Yamaguchi M: Stimulatory effect of β-alanyl-L-histidinato zinc on cell proliferation is dependent on protein synthesis in osteoblastic MC3T3-E1 cells. Moll Cell Biochem 122: 59–64, 1993

    Google Scholar 

  11. Yamaguchi M, Kishi S: Prolonged administration of β-alanyl-L-histidinato zinc prevents bone loss in ovariectomized rats. Jpn J Pharmacol 63: 203–207, 1993

    Google Scholar 

  12. Yamaguchi M, Segawa Y, Shimokawa N, Tsuzuike N, Tagashira E: Inhibitory effect of β-alanyl-L-histidinato zinc on bone resorption in tissue culture. Pharmacology 45: 292–300, 1992

    Google Scholar 

  13. Kishi S, Yamaguchi M: Inhibitory effect of zinc compounds on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 48: 1225–1230, 1994

    Google Scholar 

  14. Shuto T, Kukita T, Hirata M, Jimi E, Koga T: Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse marrow cultures. Endocrinology 134: 1121–1126, 1994

    Google Scholar 

  15. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T: Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122: 1373–1382, 1988

    Google Scholar 

  16. Mundy GR, Roodman GD: Osteoclast ontogeny and function. In: WA Peck (ed.) Bone and Mineral Research, Annual 5, Elsevier Science Publishers, Amsterdam, 1987, pp 209–279

    Google Scholar 

  17. Burstone MS: Histochemical demonstration of acid phosphatase with naphthol AS-phosphate. J Nat Cancer Inst 21: 523–539, 1958

    Google Scholar 

  18. Minkin C: Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker osteoclast function. Calcif Tissue Int 34: 285–290, 1982

    Google Scholar 

  19. Takada Y, Kusuda M, Hiura K, Sato T, Mochizuki H, Nagao Y, Tomura M, Yahiro M, Hakeda Y, Kawashima H, Kumegawa M: A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells. Bone Mineral 17: 347–359, 1992

    Google Scholar 

  20. Kurihara N, Suda T, Miura Y, Nakauchi H, Kodama H, Hiura K, Hakeda Y, Kumegawa M: Generation of osteoclasts from isolated hematopoietic progenitor cells, Blood 74: 1295–1302, 1989

    Google Scholar 

  21. Shinai DM, Rodan GA: Biphasic effects of transforming growth factor β on the production of osteoclast-like cells in mouse bone marrow cultures: The role of prostaglandins in the generation of these cells. Endocrinology 126: 3153–3158, 1990

    Google Scholar 

  22. Takahashi N, Kukita T, MacDonald BR, Bird A, Mundy GR, McManus LM, Miller M, Boyde A, Jones SJ, Roodman GD: Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures. J Clin Invest 83: 543–550, 1989

    Google Scholar 

  23. Shuto T, Jimi E, Kukita T, Hirata M, Koga T: Granulocyte-macrophage colony stimulating factor suppresses lipopolysaccharide-induced osteoclast-like cell formation in mouse marrow cultures. Endocrinology 134: 831–837, 1994

    Google Scholar 

  24. Sugimoto T, Kanatani M, Kaji H, Yamaguchi T, Fukase M, Chihara K: Second messenger signaling of PTH-and PTHRP-stimulated esteeclast-like cell formation from hemopoietic blast cells. Am J Physiol 265: E367-E373, 1993

    Google Scholar 

  25. Quest AFG, Bloomenthal J, Bardes ESG, Bell RM: The regulatory domain of protein kinase C coordinates four atoms of zinc. J Biol Chem 267: 10193–10197, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Endocrinology and Molecular Metabolism, Graduate School of Nutritional Sciences, University of Shizuoka, 52-1 Yada, Shizuoka City, 422, Japan

    Seiko Kishi & Masayoshi Yamaguchi

Authors
  1. Seiko Kishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masayoshi Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kishi, S., Yamaguchi, M. Characterization of zinc effect to inhibit osteoclast-like cell formation in mouse marrow culture: Interaction with dexamethasone. Mol Cell Biochem 166, 145–151 (1997). https://doi.org/10.1023/A:1006831227867

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006831227867

Search

Navigation